Endovascular Thrombectomy Alone Versus Intravenous Thrombolysis Plus Thrombectomy on Acute Basilar Artery Occlusion

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 338 participants.

Also called NCT05827042

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 338 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05827042
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05827042. Randomized; single masking; primary purpose treatment. Start 2023-05-09 (actual); primary completion 2026-04-07 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Endovascular Thrombectomy Alone Versus Intravenous Thrombolysis Plus Thrombectomy on Acute Basilar Artery Occlusion
Condition
Basilar Artery Occlusion
Condition
Acute Cerebrovascular Accident
Condition
Stroke Due to Basilar Artery Occlusion
Intervention (Drug)
Intravenous thrombolysis
Intervention (Procedure)
Endovascular thrombectomy
Lead sponsor
The First Affiliated Hospital of University of Science and Technology of China (class: other)

Record details

Record id
cardio:ct-nct05827042
Content hash
49db9a87990e6ae30fa18f67da6926d47d03168794f753b463fc7df808848847